American Regent Expands Pain Injection Vial Recall

Law360, New York (November 4, 2009, 3:51 PM EST) -- American Regent on Wednesday expanded its voluntary recall of Ketorolac Tromethamine Injection vials to the 15 mg/mL dose due to the presence of particulate matter, the company and the U.S. Food and Drug Administration said.

The drug is described as a nonsteroidal anti-inflammatory medication used short-term for the treatment of acute pain.

This recall came in addition to a voluntary recall initiated on Oct. 16 when the Shirley, N.Y.-based Luitpold Pharmaceuticals Inc. subsidiary recalled unexpired lots of Ketorolac Tromethamine Injection, USP, 30 mg/mL due to the...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.